FOUNDER PROFILE

Maxime Feyeux

Maxime Feyeux

Maxime Feyeux

Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone. 

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Michael Gani

Founder

Michael Gani

Co-founder of Arsitag

Tiago Craveiro

Founder

Tiago Craveiro

Head of Product and co-founder of Knokcare (formerly Knok Healthcare)

Jeffry William Tani

Founder

Jeffry William Tani

Co-founder and Chief Product Officer of Advotics

RECOMMENDED

Michael Gani

Founders

Michael Gani

Co-founder of Arsitag

Tiago Craveiro

Founders

Tiago Craveiro

Head of Product and co-founder of Knokcare (formerly Knok Healthcare)

Jeffry William Tani

Founders

Jeffry William Tani

Co-founder and Chief Product Officer of Advotics

Gift This Article

The gift link can be opened by one recipient only.

You have 19 gift credits left this month

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.